Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
26.7%
% of GDOC's 49 holdings also in FBT
40.0%
% of FBT's 31 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GDOC |
Weight in FBT |
Overlap | |
---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INC | 15.8% | 3.6% | 3.6% | |
METTLER-TOLEDO INTERNATIONAL | 9.4% | 3.5% | 3.5% | |
GENMAB A/S SPONSORED ADR | 6.7% | 3.5% | 3.5% | |
ARGENX SE ADR | 4.6% | 3.4% | 3.4% | |
EXACT SCIENCES CORP | 6.9% | 3.4% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to FBT
ELI LILLY & CO | 39.2% | |
BOSTON SCIENTIFIC CORP | 24.3% | |
ASTRAZENECA PLC | 21.6% | |
INTUITIVE SURGICAL INC | 20.1% | |
INSULET CORP | 14.6% | |
DEXCOM INC | 13.7% | |
COOPER COS INC/THE | 13.7% | |
ZIMMER HOLDINGS INC | 13.3% | |
BIOGEN IDEC INC | 12.8% | |
CSL LIMITED | 12.7% |
GDOC Underweight Relative to FBT
GRIFOLS SA-ADR | -3.9% | |
IQVIA HOLDINGS INC | -3.7% | |
QIAGEN NV | -3.6% | |
BIONTECH SE SPONSORED ADR | -3.6% | |
IONIS PHARMACEUTICALS, INC. | -3.5% | |
CHARLES RIVER LABORATORIES | -3.5% | |
AGIOS PHARMACEUTICALS INC | -3.4% | |
UNITED THERAPEUTICS CORP | -3.4% | |
EXELIXIS INC | -3.4% | |
ACADIA PHARMACEUTICALS INC | -3.3% |